Across TCGA pan-cancer cohorts, SEC61GP1 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of SEC61GP1’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where SEC61GP1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SEC61GP1 is over-expressed in tumor.
KIRC are the cancer types where SEC61GP1 tumor–normal differential expression is most reproducible.